Development of AMS
ZEG – The Center for Epidemiology and Health Research (www.zeg-berlin.de) was founded as independent research institute in 1990 - at that time as a joint venture with Infratest Germany, which became part of an internationally operating company (www.tns-infratest.com and www.tns-global.com) with offices operating in 70 countries.
ZEG Berlin has an expertise in developing research tools for surveys,including patient-reported-outcome scales as well as planning, executing, and evaluating pharmacoepidemiological studies. The institute is vastly experienced in international surveys, cohort studies as well as population and hospital based case-control studies in the field of drug safety (www.drug-safety-net.com).
International implementation of the AMS scale and research
Pharmaceutical companies involved:
Schering/ Jenapharm since 1996
Farid Saad,
Thomas ZimmermannOrganon since 2002
Annoesjka Novak Pierre Fabre since 2002
Eric Myon Solvay Pharmaceuticals since 2006 Claire Pexman-Fieth
Research teams involved:
International versions and responsible institutions/personsBelgium (MAPI)
Latvia (MAPI) Brazil (Carmita Abdo)
Lebanon (Patrick Choueiry) Bulgaria (Philipp Kumanov)
Malaysia (Geeta Appannah) Chile (Alide Salazar Molina) Mongolia (Munkhtsetsek Janlav) China (Yi Qun Gu) Nigeria (Akinyemi Akanni) Croatia (Sandra N. Sprajc, Claire Pexman-Fieth)
Norway (Johan Svartberg) Denmark (MAPI)
Netherlands (Annoesjka Novak) Netherlands (MAPI)
Poland (MAPI) English UK/USA
(Lothar Heinemann, Karin Thiele)
Portugal (Peter Potthoff) Finland (Marc Renard )
Romania (Dessislava Groseva, Claire Pexman-Fieth)
France (MAPI, Eric Myon)
Russia (MAPI)
Germany (Lothar Heinemann)
Slovenia (Jaro Lajovic, Claire Pexman-Fieth)
Hungary (Cziszer Robert, Claire Pexman-Fieth) Spain (Xavier Badia, Peter Potthoff) Indonesia (Akmal Taher) Sweden (Peter Potthoff) Italy (Giorgio Valenti, Paolo Gontero) Taiwan (Ching-Yen Chen) Japan (Naoki Itho) Thailand (Somboon Leungwattanakij) Korea (Sehyun Kim)
Turkey (Onder Canguven)
